The Diabetic Foot, December 22nd, 2007
It is difficult to predict who will develop Charcot osteoarthropathy (Charcot foot), mainly due its poorly understood aetiology. Although Charcot foot is often difficult to diagnose in its early stages, recent studies suggest that early pharmacological treatment to inhibit osteoclast activity may alter the natural history of Charcot foot (Jude et al, 2001; Pitocco et al, 2005; Tan et al, 2005). If those at risk of developing Charcot foot could be identified, treatment could be instigated at the first suspicion of a neuropathic joint developing, thus reducing morbidity and mortality. In this ...
HighBeam Research, Free Preview: 'A retrospective case study of Charcot osteoarthropathy.'... Full Membership required for unlimited access. Free 7-day trial.
Subscribers: HighBeam content is only available to HighBeam subscribers. Click the link above for more information.
